Suicidality
suicidality, −6.5
The overall baseline SIDAS score was 0 in 12 individuals (19%), 1 to 20 in 41 individuals (66%), and 21 to 50 in 9 individuals (15%). Compared with the control participants, in individuals receiving testosterone, there was a significant reduction in the SIDAS score over 3 months’ follow-up (mean difference, −6.5 points; 95% CI, −8.2 to −4.8 points; In individuals with suicidality at baseline as assessed by PHQ-9 item 9 (“Over the last 2 weeks, how often have you been bothered by thoughts that you would be better off dead, or thoughts of hurting yourself in some way?”), resolution occurred in 11 individuals (52%) with immediate testosterone commencement compared with 1 individual (5%) in standard care (